Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 35 out of 100. Genetics

Topic: Brain proteins, microglia and lab models

Previous observational studies demonstrated that lung cancer and both Alzheimer disease (AD) and Parkinson disease (PD) may be related. However, the results of different studies are still controversial, possibly due to differences in the types of lung cancer examined. To date, no research has discussed it further yet. In this study, Mendelian randomization (MR) analysis was employed to investigate the relationship between different types of lung cancer and neurodegenerative diseases. We extracted data sets related to the exposure (lung cancer) and outcomes (AD/PD) from the Integrative Epidemiology Unit open Genome-Wide Association Study project. Then, we carried out two-sample MR analyses to explore the connection between lung cancer and both AD and PD. We also conducted sensitivity analyses on positive results from the MR analysis to make sure the results were accurate. Our two-sample MR analyses revealed that lung squamous cell carcinoma (LUSC) is negatively related to AD (OR = 0.935, 95% CI [0.892-0.980], P = .005). According to the sensitivity and heterogeneity analyses, no heterogeneity (P = .223) and pleiotropy (P = .548) were observed in this positive result. Thus, the findings were reliable. The IVW findings suggested that LUSC and PD did not significantly correlate (OR = 0.920, 95% CI [0.778-1.089], P = .332). Similarly, there was no obvious connection between lung adenocarcinoma and AD (OR = 0.968, 95% CI [0.915-1.025], P = .270) and PD (OR = 0.981, 95% CI [0.851-1.130], P = .787), according to IVW results. Results of two-sample MR analyses revealed that LUSC and a decreased risk of AD may be related.

Key findings

Why it matters

This genetic analysis found that lung squamous cell carcinoma was negatively related to Alzheimer's disease, meaning it was associated with lower risk. The findings come from statistical genetic methods and do not show that having or treating lung cancer would prevent or cure Alzheimer's disease.

Study details

How this study scored 35/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 3 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 0 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 35 of 100.35 of 100 points earned65 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Medicine)
Journal's citation record 3 / 4 Medicine: journal h-index 285 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 0 / 4 Last-listed author Ling Zhu: h-index 3 (OpenAlex, whole career)
Institution's track record 0 / 3 Dali University: institution h-index 119 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41054040)
Free to read 2 / 2 Free to read
Total 35 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Zheng, W., Wang, Y. X., Zhu, E., Xu, R., & Zhu, L. (2025). Association between different types of lung cancer and neurodegenerative diseases: A two-sample Mendelian randomization study. Medicine. https://doi.org/10.1097/md.0000000000045048

Vancouver

Zheng W, Wang YX, Zhu E, Xu R, Zhu L. Association between different types of lung cancer and neurodegenerative diseases: A two-sample Mendelian randomization study. Medicine. 2025. doi:10.1097/md.0000000000045048. PMID: 41054040.

BibTeX

@article{zheng2025-41054040,
  author  = {Zheng, Wentao and Wang, Ying Xiang and Zhu, Enjiang and Xu, Rui‐Hua and Zhu, Ling},
  title   = {{Association between different types of lung cancer and neurodegenerative diseases: A two-sample Mendelian randomization study}},
  journal = {Medicine},
  year    = {2025},
  doi     = {10.1097/md.0000000000045048},
  pmid    = {41054040},
  url     = {https://doi.org/10.1097/md.0000000000045048}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Genetics

Also tagged “bodies”

1,017 studies in the library carry the topic tag “bodies”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.

Similar studies

More on Genetics

See all studies in Genetics →